The role of reactive oxygen metabolites in ulcerative colitis


Dagli Ü., Balk M., YÜCEL D., Ülker A., Över H., Saydam G., ...Daha Fazla

Inflammatory Bowel Diseases, cilt.3, sa.4, ss.260-264, 1997 (Scopus) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 3 Sayı: 4
  • Basım Tarihi: 1997
  • Doi Numarası: 10.1097/00054725-199712000-00003
  • Dergi Adı: Inflammatory Bowel Diseases
  • Derginin Tarandığı İndeksler: Scopus
  • Sayfa Sayıları: ss.260-264
  • Anahtar Kelimeler: Inflammatory bowel disease, Reactive oxygen metabolites, Ulcerative colitis
  • Lokman Hekim Üniversitesi Adresli: Hayır

Özet

Reactive oxygen metabolites (ROMs) contribute to tissue injury in inflammatory bowel disease. The aim of this study is to examine the role of ROMs in the tissue injury in ulcerative colitis (UC). The study group consisted of 27 patients with UC (14 active, 13 quiescent) and a control group of 10 patients with various anal diseases. We measured the content of malondialdehyde (MDA), superoxide dismutase (SOD), and myeloperoxidase (MPO) in colorectal biopsies. MDA was measured by the thiobarbituric acid assay. SOD and MPO were measured using the nitro blue tetrazolium and o-dianisidine methods, respectively. The MDA, SOD, and MPO tissue levels were significantly different between the patients with active UC, the patients with quiescent UC, and the control subjects (p < 0.001). A positive correlation was found between the tissue concentrations of MDA and MPO and the activity of the disease (p < 0.001). The SOD tissue concentrations were negatively correlated with the disease activity (r = -0.507, p < 0.05). © 1997 Crohn's & Colitis Foundation of America, Inc.